Impact of definitions of loss to follow-up (LTFU) in antiretroviral therapy program evaluation: Variation in the definition can have an appreciable impact on estimated proportions of LTFU

Journal of Clinical Epidemiology

Volumn 66, Issue 9, 2013, Pages 1006-1013

  Grimsrud, Anna Thora ^a   Cornell, Morna ^a   Egger, Matthias ^b   Boulle, Andrew ^a   Myer, Landon ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Antiretroviral therapy; Cohort; Loss to follow up; Program outcomes; Retention; Survival analysis

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LOSS TO FOLLOW UP; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ANTIRETROVIRAL THERAPY; COHORT; LOSS TO FOLLOW-UP; PROGRAM OUTCOMES; RETENTION; SURVIVAL ANALYSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AFRICA, SOUTHERN; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; LOST TO FOLLOW-UP; MALE; MIDDLE AGED; PROGRAM EVALUATION; TERMINOLOGY AS TOPIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84882916575     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2013.03.013     Document Type: Article

References (39)

1. Joint United Nations Programme on HIV/AIDS Together we will end AIDS 2012 Joint United Nations Programme on HIV/AIDS (UNAIDS) Geneva, Switzerland
2. S. Hoskins, I. Weller, A. Jahn, P. Kaleebu, R. Malyuta, and W. Kirungi An appraisal of indicators used to monitor the treated population in antiretroviral programmes in low-income countries AIDS 24 2010 2603 2607
3. M.W. Brinkhof, F. Dabis, L. Myer, D.R. Bangsberg, A. Boulle, and D. Nash Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries Bull World Health Organ 86 7 2008 559 567
4. E.J. Mills, and C. Nabiryo Preventing antiretroviral treatment interruptions among HIV/AIDS patients in Africa PLoS Med 10 1 2013 e1001370
5. S. Greenland Application of stratified analysis methods: basic survival analysis K.J. Rothman, S. Greenland, T.L. Lash, Modern epidemiology III ed. 2008 Lippincott Williams & Wilkins Philadelphia, PA 289 295
6. N.E. Breslow, and N.E. Day Statistical methods in cancer research: volume II - the design and analysis of cohort studies 1987 Oxford University Press Lyon, France
7. M.W.G. Brinkhof, M. Pujades-Rodriguez, and M. Egger Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and Meta-analysis PLoS One 4 2009
8. M.P. Fox, and S. Rosen Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review Trop Med Int Health 15 2010 1 15
9. S. Rosen, M.P. Fox, and C.J. Gill Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review PLoS Med 4 2007 e298
10. A. Grimsrud, N. Ford, and L. Myer Defaulting from antiretroviral treatment programmes in sub-Saharan Africa: a problem of definition Trop Med Int Health 16 3 2011 390 391 author reply 2
11. B.H. Chi, R.A. Cantrell, A. Mwango, A.O. Westfall, W. Mutale, and M. Limbada An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs Am J Epidemiol 171 2010 924 931
12. B.H. Chi, C.T. Yiannoutsos, A.O. Westfall, J.E. Newman, J. Zhou, and C. Cesar Universal definition of loss to follow-up in HIV treatment programs: a Statistical analysis of 111 Facilities in Africa, Asia, and Latin America PLoS Med 9 10 2011 e1001111 http://dx.doi.org/10.1371/journal.pmed.1001111
13. M. Egger, D.K. Ekouevi, C. Williams, R.E. Lyamuya, H. Mukumbi, and P. Braitstein Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa Int J Epidemiol 41 2012 1256 1264
14. S.J. Gange, M.M. Kitahata, M.S. Saag, D.R. Bangsberg, R.J. Bosch, and J.T. Brooks Cohort profile: the North American AIDS cohort collaboration on research and design (NA-ACCORD) Int J Epidemiol 36 2007 294 301
15. C.C. McGowan, P. Cahn, E. Gotuzzo, D. Padgett, J.W. Pape, and M. Wolff Cohort profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the international Epidemiologic databases to evaluate AIDS (IeDEA) programme Int J Epidemiol 36 2007 969 976
16. M. Cornell, K. Technau, L. Fairall, R. Wood, H. Moultrie, and G. van Cutsem Monitoring the South African national antiretroviral treatment programme, 2003-2007: the IeDEA Southern Africa collaboration S Afr Med J 99 2009 653 660
17. M. Cornell, A. Grimsrud, L. Fairall, M.P. Fox, G. van Custem, and J. Giddy Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007 AIDS 24 2010 2263 2270
18. S. Toure, B. Kouadio, C. Seyler, M. Traore, N. Dakoury-dogbo, and J. Duvignac Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants AIDS 22 2008 873 882
19. P. MacPherson, M. Moshabela, N. Martinson, and P. Pronyk Mortality and loss to follow-up among HAART initiators in rural South Africa Trans R Soc Trop Med Hyg 103 2009 588 593
20. P. Collini, U. Schwab, S. Sarfo, J. Obeng-Baah, B. Norman, and D. Chadwick Sustained immunological responses to highly active antiretroviral therapy at 36 months in a Ghanaian HIV cohort Clin Infect Dis 48 2009 988 991
21. Majuba P, Westreich D, Maskew M, MacPhail P, Fox MP, Ngobeni L, et al. Differences in risk factors for early and late losses to follow-up in a public HAART clinic in South Africa. 16th Conference on Retroviruses and Opportunistic Infections (CROI); Montreal, Canada 2009.
22. P. Braitstein, M.W. Brinkhof, F. Dabis, M. Schechter, A. Boulle, and P. Miotti Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries Lancet 367 2006 817 824
23. O. Keiser, H. Tweya, P. Braitstein, F. Dabis, P. MacPhail, and A. Boulle Mortality after failure of antiretroviral therapy in sub-Saharan Africa Trop Med Int Health 15 2 2010 251 258
24. M. May, A. Boulle, S. Phiri, E. Messou, L. Myer, and R. Wood Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes Lancet 376 2010 449 457
25. A. Boulle, G. Van Cutsem, K. Hilderbrand, C. Cragg, M. Abrahams, and S. Mathee Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa AIDS 24 2010 563 572
26. G. Van Cutsem, N. Ford, K. Hildebrand, E. Goemaere, S. Mathee, and M. Abrahams Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis PLoS One 6 2 2011 e14684 http://dx.doi.org/10.1371/journal.pone.0014684
27. G.P. Bisson, T. Gaolathe, R. Gross, C. Rollins, S. Bellamy, and M. Mogorosi Overestimates of survival after HAART: implications for global scale-up efforts PLoS One 3 2008 e1725
28. M.B. DeSilva, S.P. Merry, P.R. Fischer, J.E. Rohrer, C.O. Isichei, and S.S. Cha Youth, unemployment, and male gender predict mortality in AIDS patients started on HAART in Nigeria AIDS Care 21 2009 70 77
29. A. Johannessen, E. Naman, B.J. Ngowi, L. Sandvik, M.I. Matee, and H.E. Aglen Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania BMC Infect Dis 8 2008 52
30. M.C. Marazzi, G. Liotta, P. Germano, G. Guidotti, A.D. Altan, and S. Ceffa Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings AIDS Res Hum Retroviruses 24 2008 555 560
31. L. Palombi, M.C. Marazzi, G. Guidotti, P. Germano, E. Buonomo, and P. Scarcella Incidence and predictors of death, retention, and switch to second line regimens in antiretroviral treated patients in sub-Saharan African sites with comprehensive monitoring availability Clin Infect Dis 48 2009 115 122
32. H. Bussmann, C.W. Wester, N. Ndwapi, N. Grundmann, T. Gaolathe, and J. Puvimanasinghe Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program AIDS 22 2008 2303 2311
33. C. Orrell, G. Harling, S.D. Lawn, R. Kaplan, M. McNally, and L.G. Bekker Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited Antivir Ther 12 2007 83 88
34. K. Kranzer, and N. Ford Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review Trop Med Int Health 16 2011 1297 1313
35. K. Kranzer, J.J. Lewis, N. Ford, J. Zeinecker, C. Orrell, and S.D. Lawn Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors J Acquir Immune Defic Syndr 55 2010 e17 e23
36. F. Schöni-Affolter, O. Keiser, A. Mwango, J. Stringer, B. Ledergerber, and L. Mulenga Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland PLoS One 6 12 2011 e27919
37. K. Clouse, A. Pettifor, M. Maskew, J. Bassett, A. Van Rie, and C. Gay Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting AIDS 27 2013 645 650
38. WHO Adherence to long-term therapies: evidence for action 2003 World Health Organization Geneva, Switzerland
39. M.P. Fox, A. Brennan, M. Maskew, P. Macphail, and I. Sanne Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa Trop Med Int Health 15 2010 405 413